pharmaceutical – CFN Media

Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1…

Ryan Allway
October 22, 2024

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company’s…

Ryan Allway
February 15, 2024

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of…

Ryan Allway
October 22, 2024

Graphite One Receives Indication for Up to $325 Million Financing from the U.S. Export-Import Bank for U.S.-Based Advanced Graphite Material Supply Chain Project

EXIM Letter of Interest is non-binding and indicates potential financing could provide…

Ryan Allway
October 21, 2024

Graphite One Enters Into Agreements Providing Exclusive Access to Industry Leading Anode Manufacturing Technology

Execution of the Graphite One-Chenyu Agreements marks key step in providing the…

Ryan Allway
October 21, 2024

Interview with Stallion Uranium CEO Drew Zimmerman

Exploring 3000+ Sq/Kms in Canada’s Western Athabasca Basin Against the backdrop of…

Robin Lefferts
October 11, 2024